AB Science S.A. (EPA:AB)
France · Delayed Price · Currency is EUR 0.5430
-0.0220 (-3.89%)
Oct 22, 2026, 5:35 PM CEST
AB Science Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1.16 | 1.17 | 1.07 | 0.97 | 0.96 | 1.61 | |
Revenue Growth | 12.66% | 9.52% | 10.51% | 1.25% | -40.39% | 1.52% |
Cost of Revenue | -0.22 | 0.2 | -0.18 | 0.38 | 0.03 | 0.11 |
Gross Profit | 1.38 | 0.98 | 1.25 | 0.59 | 0.93 | 1.5 |
Selling, General & Admin | 3.45 | 2.43 | 3.4 | 3.54 | 3.52 | 4.07 |
Research & Development | 4.67 | -2.09 | 3.94 | 10.48 | 13.35 | 11.23 |
Operating Expenses | 8.42 | 0.34 | 7.33 | 14.02 | 16.87 | 15.3 |
Operating Income | -7.05 | 0.64 | -6.08 | -13.43 | -15.94 | -13.81 |
Interest Expense | -1.34 | -1.27 | -1.12 | -1.53 | -0.82 | -0.02 |
Interest & Investment Income | 0.28 | 0.24 | 0.2 | 0.22 | - | - |
Currency Exchange Gain (Loss) | 0.84 | 0.97 | -0.07 | 0.42 | 0.13 | -0.02 |
Other Non Operating Income (Expenses) | 1.86 | -2.14 | -0.76 | 2.33 | 3.02 | -0.58 |
Pretax Income | -5.41 | -1.56 | -7.83 | -11.99 | -13.61 | -14.43 |
Income Tax Expense | - | - | - | - | 0 | 0.04 |
Net Income | -5.41 | -1.56 | -7.83 | -11.99 | -13.62 | -14.46 |
Net Income to Common | -5.41 | -1.56 | -7.83 | -11.99 | -13.62 | -14.46 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 66 | 61 | 53 | 50 | 47 | 48 |
Shares Outstanding (Diluted) | 66 | 61 | 53 | 50 | 47 | 48 |
Shares Change | 16.59% | 14.94% | 7.27% | 5.36% | -0.80% | 7.45% |
EPS (Basic) | -0.08 | -0.03 | -0.15 | -0.24 | -0.29 | -0.30 |
EPS (Diluted) | -0.08 | -0.03 | -0.15 | -0.24 | -0.29 | -0.30 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -4.74 | -4.57 | 0.37 | -17.22 | -18.12 | -17.74 |
Free Cash Flow Per Share | -0.07 | -0.07 | 0.01 | -0.35 | -0.38 | -0.37 |
Gross Margin | 118.84% | 83.30% | 116.42% | 60.51% | 96.76% | 93.09% |
Operating Margin | -608.90% | 54.43% | -567.44% | -1384.43% | -1663.67% | -859.24% |
Profit Margin | -467.50% | -132.62% | -730.50% | -1235.57% | -1421.19% | -900.00% |
Free Cash Flow Margin | -409.68% | -389.35% | 34.52% | -1774.84% | -1890.92% | -1104.05% |
EBITDA | -7 | 0.75 | -5.69 | -12.8 | -15.53 | -13.32 |
EBITDA Margin | - | 63.46% | - | - | - | - |
D&A For EBITDA | 0.05 | 0.11 | 0.39 | 0.63 | 0.41 | 0.49 |
EBIT | -7.05 | 0.64 | -6.08 | -13.43 | -15.94 | -13.81 |
EBIT Margin | - | 54.43% | - | - | - | - |
Revenue as Reported | 1.16 | 1.17 | 1.07 | 0.97 | 0.96 | 1.61 |